Immunity against neuraminidase is important to consider in development of therapeutics and influenza vaccines with improved efficacy and protection.
Analysis of 10 years of data revealed that racial and ethnic minorities experienced more adverse outcomes from severe influenza.
Researchers conducted a systematic review and meta-analysis that compared outcomes of 4 antiviral agents for the treatment of patients with seasonal influenza.
Patients exposed to influenza-like illness in the medical office setting are more likely to return with a similar illness in the following two weeks.
As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.
The researchers tested their hypothesis that a decrease in respiratory virus incidence would be associated with a reduction in inappropriate ambulatory antibiotic orders.
A team of investigators sought to estimate the burden of acute respiratory illness in ambulatory care settings for 12 respiratory viruses in Washington state during the 2018-2019 influenza season.
Investigators conducted a systematic review and meta-analysis of 37 studies that used a test-negative design to evaluate IVE against influenza-associated hospitalization in children.
Investigators compared the immunogenicity and safety of the influenza vaccine of different intradermal vaccine doses with a standard intramuscular dose.
Researchers used Medicare claims data to estimate differences in influenza vaccination rates among patients of female vs male physicians.
Researchers assessed the impact on pooled adjusted end-season vaccine effectiveness estimates from outpatient test-negative design studies.
Flucelvax Quadrivalent is a subunit influenza vaccine manufactured using cell derived candidate vaccine viruses; it does not contain egg proteins or antibiotics.
Researchers compared safety, reactogenicity, and changes in Health-Related Quality of Life scores of aIIV3 vs HD-IIV3 flu vaccines in older adults.
Researchers analyzed pooled patient data from 2 hospital-based respiratory virus surveillance cohorts to assess the burden of noninfluenza respiratory virus (NIRV) infection.
Researchers compared respiratory viral infections other than severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020 to corresponding periods in the previous 5 years.
In December 2020, researchers conducted a survey of 1027 adults to determine percentage of those receiving, or intending to receive, influenza vaccination.
The objective of this quasi-experimental observational study was to measure the effect of states’ hospital worker influenza vaccination laws on pneumonia and influenza mortality.
Study authors evaluated influenza-vaccinated patients hospitalized with an influenza-like illness to identify characteristics associated with being at increased risk for hospitalization with influenza.
The AS03-adjuvanted H1N1 influenza vaccine was linked to an increased narcolepsy incidence, but this narcolepsy did not clinically differ significantly from sporadic cases.
There may be increased hospitalization risk from influenza infection in patients with obstructive sleep apnea who do not use continuous positive airway pressure.